Hepatitis C: Resources for People with Hepatitis C
For most people with hepatitis C, drugs are now available to prevent hepatitis C from becoming a chronic disease. An acute infection may clear on its own without treatment in about 25% of people. Since 2011, new treatments have been available for persons living with hepatitis C and have shown to cure 90% of persons with 8–12 weeks of oral therapy.
Below are links to several resources that can assist people in understanding hepatitis C and in managing their health.
- Abbvie/MAVYRET
- Genentech/Pegassist
- Gilead/Sovaldi
- Janssen/Olysio
- Pharmaceutical Company Patient Assistance and Cost-sharing Assistance Programs: Hepatitis
- Common Patient Assistance Program: Application and Companion Document
Information on how to apply for pharmaceutical assistance programs that offer medicines at little or no cost to eligible patients. - Wisconsin AIDS/HIV Drug Assistance Program
The Wisconsin AIDS/HIV Drug Assistance Program (ADAP) provides eligible HIV-infected persons access to HIV-related antiretroviral drugs and prophylactic medications. The ADAP drug formulary includes hepatitis C virus (HCV) medications for persons co-infected with HIV and HCV as well as vaccines for hepatitis A and B.
- Hepatitis C Infection - General Information (Multiple Languages)
- Hepatitis A, B, and C Summary Table (PDF)
- Hepatitis C in Wisconsin: Increase Among Young People Who Inject Drugs, P-02322 (PDF)
- American Liver Foundation
- CDC (Centers for Disease Control and Prevention) - Division of Viral Hepatitis
- CDC Hepatitis Publications and Information Resources
- Immunization Action Coalition
- Viral Hepatitis National Strategic Plan, HHS
- Division of Viral Hepatitis: 2025 Strategic Plan (cdc.gov)
- Wisconsin – Hepatitis C: State of Medicaid Access Report Card
- Hep ElimiNATION: Wisconsin Viral Hepatitis Elimination Report Card
- Hepatitis C in Wisconsin – Summary Report, 2021
- Wisconsin Hepatitis C Virus Surveillance Annual Review, 2021
- Recording and slides from the Wisconsin Hepatitis C Elimination Community Webinar